FTC Clarification Of Law On Citizen Petitions Could Bring Antitrust Scrutiny
This article was originally published in The Tan Sheet
Executive Summary
The Federal Trade Commission wants to clarify through case law that repeated petitioning of the government could bring antitrust enforcement, even if petitioners make scientific and regulatory arguments
You may also be interested in...
Adams’ Suit Could Delay ANDA For URL/Mutual’s Mucinex Generic
A lawsuit filed by Adams Respiratory Therapeutics could bring a stay of up to 30 months on FDA's approval of Mutual Pharmaceuticals and United Research Laboratories' application for a generic version of Adams' Mucinex extended-release expectorant product
Follow-On Brand Drugs Could Draw FTC Anticompetitive Scrutiny
The introduction of certain follow-on brand drugs as the original product nears patent expiration could raise anticompetitive concerns at the Federal Trade Commission, according to FTC Commissioner Pamela Harbour
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC